Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of California, San Diego
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Primary lung cancer (any type) or dominant lung metastases from other primary cancers.
Patients must have either measurable or evaluable disease.
Karnofsky performance status ≥ 70%.
Greater than 18 years of age.
Life expectancy \> 3 months.
3 week elapse from previous cytotoxic therapy (except for erlotinib or hormonal therapy, which can be ongoing) with side effects improved to grade 2 or less, and no prior radiotherapy to the lung.
Adequate organ function.
Treated brain metastases, if present, with toxicities improved to grade 2 or less.
Willingness and ability to sign a written informed consent.
You may not be if
Prior radiation to the largest lesion in the lung.
Current pregnancy or breast-feeding.
Unwillingness or inability to practice contraception.
Renal insufficiency.
Comorbidities of grade 3 or greater.
Concurrent medical or psychiatric conditions as defined by the treating physician which would preclude safe performance of study procedures or compromise the ability of the patient to consent to study.
Clareo Health | Pilot Study of Intra-Arterial Cisplatin With IV Thiosulfate in Patients With Lung Cancer or Lung Metastases
